About Us

History

  1. Home
  2. About Us
  3. History
Twitter Facebook Google E-mail Print
  1. 12.2017 Radiofrequency ablation shows excellent therapeutic effects for recurrent thyroid cancer

    Radiofrequency ablation (RFA), which involves removing benign lumps from the thyroid gland with radiofrequency energy without surgery, has been shown to be effective even in patients with recurrent malignant thyroid cancer. A team led by Professor Baek Jeong-hwan of the Department of Radiology performed RFA to treat recurrent thyroid cancer in elderly patients, with high surgical risks, or in an area where it is difficult to perform surgery from September 2008 to April 2012. They reported that the sizes of the tumors were reduced by at least 95% as a result. With the effectiveness and safety of RFA for recurrent thyroid cancer, it has recently been selected as a new health technology by the Ministry of Food and Drug Safety.

  2. 12.2017 Infectious disease preparedness training to create safe hospital

    A mock training was carried out on December 6 to better prepare ourselves for an infectious disease outbreak. The training was conducted under a hypothetical scenario, where a pregnant woman suspected of MERS came in for an emergency C-section. There were around 50 medical professionals and staff members from the departments of Infectious Diseases, Anesthesiology and Pain Medicine, Obstetrics and Gynecology, and Pediatrics as well as Surgical Nursing Team 6, Outpatient Nursing Team 2, and ICU Nursing Team.

  3. 12.2017 Grade 1 in coronary artery bypass surgery based on HIRA assessment

    Asan Medical Center received Grade 1 in the Coronary Artery Bypass Evaluation carried out by the Health Insurance Review and Assessment Service (HIRA). AMC received excellent scores in all of the assessment sections including ▲ number of coronary artery bypass operations, ▲ rate of using internal thoracic arteries during surgery, ▲ rate of prescribing aspirin at discharge, ▲ rate of reoperation due to post-op hemorrhaging or hematoma, ▲ mortality rate within 30 days after surgery, and ▲ duration of post-op hospitalization.

  4. 12.2017 The AMC Heart Institute became the first in Korea to perform 400 aortic valve stenting operations. They even recorded a success rate of 97%. A team formed by Professor Park Seung-jung, Associate Profe

    The AMC Institute of Biomedical Engineering Research was selected as Intermediary Clinical Trial Support Center for Medical Devices, supported by the Ministry of Health and Welfare. This is part of the project aimed at reinforcing the capacity to develop high-value-added medical devices and creating a research and development (R&D) ecosystem by setting up an intermediary center for supporting the clinical trials on medical devices using the infrastructure set up within the hospital. As an intermediary center, the AMC Institute of Biomedical Engineering Research will play the role of a hub, enabling medical device manufacturers and researchers involved in medical device development to engage in close collaborations for research purposes.

  5. 12.2017 AMC performs 400th aortic valve stenting surgery without open heart surgery

    The AMC Heart Institute became the first in Korea to perform 400 aortic valve stenting operations. They even recorded a success rate of 97%. A team formed by Professor Park Seung-jung, Associate Professor Park Duk-woo and Assistant Professor Ahn Jung-min of the Department of Cardiology performed their first aortic valve stenting surgery in March 2010 and recorded their 300th operation in January 2017. In less than a year thereafter, they have performed 100 operations. Based on their accumulated know-how and experience, the success rate for the recent 100 operations was recorded to be 98%.

  6. 12.2017 Patients with non-alcoholic fatty liver disease at higher risk for colon cancer (men) and breast cancer (women)

    Research has shown that non-alcoholic fatty liver disease is associated with a higher risk of colon cancer for men and breast cancer for men, in addition to liver cancer. A research team formed by Professor Lee Han-chu and Associate Professor Choi Jae-won of Gastroenterology and Professor Kim Gia-e of Health Medicine tracked around 25,000 patients who had undergone health examinations for 7.5 years, on average. The results of the review showed that male and female patients diagnosed non-alcoholic fatty liver disease were at double the risk of developing colon cancer and breast cancer, respectively, compared to the control group.

  7. 12.2017 Aggressive approach needed for cerebral infarction even after golden time

    A research team headed by Professor Seo Dae-cheol of the Neurological Intervention Clinic recently announced that even in cases where 6 hours have lapsed after the onset of a cerebral infarction, if the patient has not suffered significant brain damage, neurological interventions have sufficient therapeutic effects and are safe. Professor Seo’s team analyzed the data on 98 patients who visited the Emergency Room of AMC for cerebral infarction caused by vascular occlusion over the course of two years from January 2014. Among them, a comparison was made between 32 patients who received treatment within 6 hours of the onset of cerebral infarction and 32 patients who received treatment after 6 hours, and the results showed no difference between the two groups in terms of their condition at discharge and the mortality rate.

  8. 12.2017 Successful hosting of symposium by AMC Pulmonary Hypertension & Venous Thrombosis Center

    The AMC Pulmonary Hypertension & Venous Thrombosis Center held the 2017 Asan Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Symposium at the grand auditorium (B1) Asan Institute for Life Sciences and the small auditorium (6F) in the East Building for two days on December 15 and 16. The symposium held for the third time this year was conducted under the title, “All About Balloon Dilatation of the Pulmonary Valves.” On the first day, there was a live broadcast of pulmonary angiography and pulmonary balloon angioplasty for the attendees to have an up-close look at the procedures. Professor Nick Kim from the University of California San Diego Medical Center and Professor Hiromi Matsubara from Okayama Medical Center in Japan attended the event to share their treatment experiences and give lectures on the latest therapeutic trends.

  9. 12.2017 Customized treatment of patients with intractable breast cancer based on blood test

    A team led by Professor Kim, Sung-bae of the Department of Oncology recently announced that customized treatment is now possible, based on a diagnosis of triple-negative breast cancer by a blood test. Professor Kim’s team also revealed that the gene mutations identified in the breast cancer tissues of triple-negative breast cancer patients are 100% consistent even in the blood tests. Gene mutation test using blood is advantageous in that it can avoid the hassle of biopsy to find an existing pathologic tissue or to sample a new tissue and that the test can be performed repeatedly on the blood sample several times.

  10. 11.2017 Medical Genetics Center successfully holds international symposium

    The Medical Genetics Center International Symposium was held at the grand auditorium (B1) of Asan Institute for Life Sciences on November 3. This year’s symposium was held under the title, “Prevention and Treatment of Genetic Diseases: Current and Future Outlook,” in the presence of some 300 domestic and foreign medical professionals and researchers including Senior Researcher Seng Cheng from the US Sanofi Genzyme Rare Disease Research Center and Professor Eto Yoshikatsu from the Institute of Neurological Science in Japan. There were presentations on ▲new medicine development models for rare genetic diseases such as lysosomal storage disease, ▲ molecular therapy for genetic neurometabolic disorders, and ▲ financing plans for the development of therapeutic agents for rare diseases.

  11. 11.2017 Successful hosting of international conference on coronary interventions

    The International Conference on Coronary Interventions, hosted by the Cardiovascular Research Foundation and sponsored by the AMC Heart Institute, was held for two days from November 30. Around 440 cardiologists and related professionals from 21 countries including the United States, Japan, India and China took part in the conference. Of particular note, the leading authorities in the field of CV interventions including Professor Antonio Colombo from Italy, Professor Toshiya Muramatsu from Japan, and Professor Teguh Santoso from Indonesia attended the event, thereby bolstering the prestige of the conference.

  12. 11.2017 AMC ranks No. 1 in Call Center Quality Index

    Asan Medical Center was ranked No. 1 in the General Hospital category in the 2018 Call Center Quality Index Survey overseen by the Korean Standards Association (KSA) for two years in a row. An official at KSA revealed that AMC received especially high scores for ▲ “enthusiasm (enthusiastic attitude shown when responding to customer inquiries)” and ▲ “reliability (identifying and resolving problems in a professional manner).” AMC scored 87.3 points in the monitoring assessment and surpassed the average of 81.6 points by a significant degree.

  13. 11.2017 Plastic surgeons Koh Kyung-suck, Hong Joon-pio and Choi Jong-woo writes worldwide textbook for doctors

    Professors Koh Kyung-suck, Hong Joon-pio and Choi Jong-woo from the Department of Plastic Surgery participated as the main writers for an official textbook that is a must-read for plastic surgeons worldwide. The newly published textbook is the 4th revised edition of “New Neligan's Plastic Surgery.” Professors Koh and authored the part on “Eye and Nose Plastic Surgery and Maxillofacial Surgery for Asians,” while Professor Hong wrote “Lower Limb Reconstruction Using Flaps.” The part co-authored by professors Koh and Choi had been written by Japanese plastic surgeons until the early 2000s. They compiled all the facial cosmetic surgery techniques applied by Korean plastic surgeons that have created the boom of “Hallyu (Korean wave) plastic surgery” in the textbook.

  14. 11.2017 Cardiologist Park Seung-jeong chosen as one of world’s top 1% researchers

    Professor Park Seung-jeong of the Department of Cardiology was named one of the world’s most influential researchers in 2017, thereby gaining recognition for his research capacity as one of the world’s top 1% researchers. Professor Park has been changing the paradigm of heart disease treatment through research on stenting procedures, cardiovascular function tests, and cardiac rehabilitation. Also, he became the first Korean researcher to publish five papers in the New England Journal of Medicine, which is the most highly regarded journal in academia.

  15. 11.2017 AMC, first to successfully complete living lung transplant in Korea

    Asan Medical Center became the first hospital in Korea to successfully complete a living lung transplant on a 20-year-old female patient, suffering from idiopathic pulmonary hypertension, by transplanting parts of the lungs from her father and mother on October 21. AMC’s lung transplant team presented a report to the government authorities, National Assembly, Korean Network for Organ Sharing (KONOS) and Korean Society for Transplantation to convince them of the justification for the transplant, as living lung transplants cannot be carried out under the current law. With the parents’ earnest desire to help their daughter and the medical staff’s strong commitment to save her life, the living lung transplant was successfully carried out on October 21, and the patient was able to get off the ventilator in just 6 days after surgery. She was discharged in good health on November 29.

  16. 11.2017 AMC wins prize at Korea Design Award

    AMC was recently honored with the Prime Minister’s Prize in the Design Management category of the Korea Design Award, hosted by the Ministry of Trade, Industry and Energy (MOTIE) and supervised by Korea Institute of Design Promotion. The Korea Design Award aims to award exemplary enterprises that have contributed to industrial advancements with leading design management. Our hospital received the award in recognition of our efforts to innovate all of our processes to be oriented toward the patients in order to ensure differentiated medical services and patient experience.

  17. 11.2017 Record-setting 500th direct cerebrovascular bypass surgery

    The team headed by Professor Ahn Jae-sung of the Department of Neurosurgery announced that they have recently performed their record-setting 500th direct cerebrovascular bypass surgery since executing its first case in 2002. Direct cerebrovascular bypass surgery involves bringing in blood vessels from the scalp outside the skull to connect them directly to the blood vessels inside the cranium.  It is considered one of the most difficult types of surgery, as it requires extensive clinical experience and a high level of concentration in order to maintain the blood flow after connecting blood vessels with a diameter of 0.7~1 mm, on average. The surgery is performed to treat a wide range of brain diseases and is known to be highly effective in treating especially complicated cerebral aneurysms, moyamoya disease, and cerebral infarction.

  18. 10.2017 Asan Foundation hosts commemorative event for 40th anniversary

    The Asan Foundation held an event to commemorate the 40th anniversary of its establishment at Grand InterContinental Seoul on October 26. The event was attended by 450 guests including Chung Mong-joon, the Chairman of the Foundation, as well as the board members and advisory committee members of the Foundation and the medical staff and employees of the hospital. Chairman Chung Mong-joon said, "The Asan Foundation was founded in 1977 when people were unfamiliar with the term, ‘welfare,’ with the commitment to ‘helping the neighbors with the biggest hardships in our society,’” and reminded the attendees of the purpose of establishing the foundation.

  19. 10.2017 ASM Clinical Trial Center, Korea’s first to acquire international quality management certification

    The ASM Clinical Trial Center became the first in Korea to acquire the international quality management system certification (ISO 9001). With this, the Center has gained the recognition for meeting the international standard for imaging-related services provided by the Radiology Support Office from the image utilization planning stage for clinical trials to the actual imaging and analysis stages. The certification was granted based on the results of the assessment of the overall quality of the quality management system concerning the ▲ establishment of a protocol for clinical trial imaging, ▲ development of a clinical trial image management system, ▲ construction of an image database, and ▲ advanced imaging techniques and analysis services. The validity period for the certification, which lasts three years, will end in October 2020.

  20. 10.2017 Asan Medical Center recorded 30,000 cases of breast cancer surgery. The number of breast cancer surgery performed at our hospital was merely 13 in 1989, but it increased to 10,000 in 2007 and 20,000 i

    It has been found that the level of safety of robotic surgery for kidney cancer patients is no different from laparoscopic surgery, according to a study. Jeong In-gap, Associate Professor of Urology, analyzed the data on 23,753 patients, who had undergo complete nephrectomy through either robotic surgery or laparoscopic surgery in the United States from 2003 to 2015, in collaboration with Stanford University and Harvard University research teams. It was recently announced that the post-op complication rate and the duration of hospital stay were found to be similar between the two groups, based on the analysis.

  21. 10.2017 30,000 cases of breast cancer surgery, with increase in breast-conserving surgery

    Asan Medical Center recorded 30,000 cases of breast cancer surgery. The number of breast cancer surgery performed at our hospital was merely 13 in 1989, but it increased to 10,000 in 2007 and 20,000 in 2013. The latest achievement has come four years thereafter. The Breast Cancer Center analyzed the patients who had undergone breast cancer surgery at our hospital in the past 20 years between 1995 and 2014, and found that ▲ the portion of early-stage breast cancer patients rose from 37.8% to 57.8%, ▲ the ratio of breast-conserving surgery cases to all breast surgery cases increased from 10% to approx. 66%, and ▲ the ratio of simultaneous breast resection and reconstruction cases increased from 24% to 50%.

  22. 09.2017 Presentation of research findings that “ADHD children likely have other physical disease”

    Attention deficit hyperactivity disorder (ADHD), which typically occurs in childhood, is characterized by inattention, impulsivity and hyperactivity. It is known that ADHD children often have other mental illnesses such as oppositional defiant disorder (ODD) and anxiety disorder. According to the analysis of the data from the Health Insurance Review and Assessment Service (HIRA) conducted by a team led by Associate Professor Kim Hyo-won of the Department of Psychiatry and full-time clinical lecturer Park Gi-jeong, ADHD children have a higher chance of having a physical disease or disorder including endocrine and metabolic diseases such as diabetes and obesity.

  23. 09.2017 Asan Medical Center was ranked 1st in the general hospital category in the Customer Satisfaction Survey on Korean Industries for five years in a row. The survey supervised by Korea Management Associat

    Asan Medical Center carried out its 10,000th robotic surgery and held an event to celebrate.

    This is an especially meaningful achievement, as we surpassed the 1,000 operation mark in 2010 and 5,000 operation mark in 2014 after performing our first robotic surgery in 2007, and recorded 5,000 cases in just three years thereafter. The AMC Robotic Training Center, which opened its doors in 2013 to train medical professionals in the highly difficult robotic surgery, recently hosted its 500th education session. Around 160 Korean and foreign medical professionals paid a visit to our hospital to receive training in robotic surgery, of whom 120 were from Australia, Japan and other foreign countries.

  24. 09.2017 No. 1 in Customer Satisfaction Survey by KMAC for 5 consecutive years

    Asan Medical Center was ranked 1st in the general hospital category in the Customer Satisfaction Survey on Korean Industries for five years in a row. The survey supervised by Korea Management Association Consulting (KMAC) is one of the most prominent customer satisfaction surveys in Korea that aims to examine the level of contribution to the improvement of the quality of life and rights and interests of consumers by enterprises, organizations, etc. The results of the 2017 survey showed that Asan Medical Center recorded the highest score for the “reliability of the medical staff” among multiple assessment items including the quality of medical service and reliability of the hospital.

  25. 09.2017 Inflammatory Bowel Disease Center trains medical professionals from Vietnam

    The Inflammatory Bowel Disease Center conducted the International Education Program on Inflammatory Bowel Disease for two days from September 14. There were 6 participants including doctors from the departments of gastroenterology, surgery and pathology and pharmacists from Vietnam. They sat in lectures on ▲ the diagnostic methods for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, ▲ imaging and pathological assessment methods for inflammatory bowel disease, and ▲ surgery and treatment cases for inflammation growth disease. Asan Medical Center has been holding an annual symposium to share past cases with domestic and foreign doctors for the purpose of enhancing the level of research and care related to inflammatory bowel disease.

  26. 09.2017 Selected by MSIP for creation of new drug development platform using medical big data

    The Clinical Research Center has been selected by the Ministry of Science and ICT (MSIP) for the Project on the Establishment Open Platform for Integrated Longitudinal Clinical and Omics Information and Development of Technology for Multi-institutional Use for Reinforcing the Capacity of New Anticancer Drug Development. This project aims to establish an open platform for securing medical big data on colorectal cancer, gastrointestinal cancer, tumor tissue, blood, and genome and standardizing and anonymizing the data so that they can be utilized in the new drug development efforts.

  27. 09.2017 Signing of Joint Research Agreement with SNU Hospital and SNU Bundang Hospital

    Asan Medical Center signed a three-party business agreement for joint research on medical big data with Seoul National University (SNU) Hospital and Seoul National University (SNU) Bundang Hospital on September 20. The agreement was on mutual cooperation in ▲ research on the utilization of medical big data based on electronic communications technology, ▲ medical data analyses and propagation of artificial intelligence technology, and ▲ sharing and dissemination of knowledge. World-class competitiveness is expected to be gained from incorporating the medical big data and cutting-edge technologies of the three hospitals. Also, by building an open academia-industry-research innovation platform and discovering creative ideas to resolve various medical challenges, the three hospitals will be able to provide medical services of the highest standard to even more patients.

  28. 09.2017 New design for stone sign of Asan Medical Center

    The new stone sign of Asan Medical Center was erected on September 25. It was designed to convey our commitment to begin anew, as a medical institution that leads the advances in medical technology and provides differentiated services. The new stone sign, which is 7.1m x 1.7m in size, contains the names of not only Asan Medical Center, but also Asan Foundation, University of Ulsan College of Medicine, and Asan Institute for Life Sciences.

  29. 09.2017 Successful hosting of the 8th Cancer Institute Symposium

    The Cancer Institute Symposium was held at the grand auditorium on the sixth floor of the East Building on September 1. The recent symposium comprised of plenary sessions and cancer-specific sessions was held under the title, “Future Medicine: Genetics, Cancer Immunity and Artificial Intelligence.” During the morning session, scholars from Korea and abroad had a chance to share the latest insights on the major issues of future medicine. As for the afternoon program, there were in-depth discussions on individual cancers. This symposium served as an impetus for in-depth discussions of the major issues concerning genetics, cancer immunity and artificial intelligence to conquer cancer in the future.

  30. 08.2017 Interdisciplinary team for stroke dramatically shortens treatment time using thrombolytic agent

    Around 80% of strokes, which is the No. 1 cause of death, are ischemic strokes (cerebral infarction) caused by obstructed blood vessels. A team led by Professor Kim Jong-sung and Associate Professor Jeon Sang-beom at Asan Medical Center in Seoul carried out regular education sessions to instruct 119 paramedics to screen for patients suspected of having a stroke and contact a hotline before transporting them to the hospital. They also organized an interdisciplinary team dedicated to stroke treatment, thereby dramatically shortening the time it takes for stroke examination and treatment procedure. Through these efforts, the average time it takes for a stroke patient to receive thrombolytic therapy after arrival at the hospital has reportedly been reduced from 46 minutes to 20.5 minutes. In addition, the percentage of patients receiving thrombolytic therapy increased 1.6-fold from 9.8% to 15.8%, and the incidence of cerebral hemorrhage, a complication of the procedure, decreased from 12.6% to 2.1%.

  31. 08.2017 First evidence of effectiveness of new targeted therapeutic agent for intractable breast cancer

    Triple-negative breast cancer, a type of breast cancer that occurs irrespective of the amplification of female hormones or genes (HER2), accounts for 15-20% of all breast cancer cases. Even if it responds to anticancer drugs, there are often recurrences, and it is also difficult to treat due to rapid progression. Professor Kim, Sung-bae of the Department of Oncology recently announced the findings of a multi-center international study demonstrating the effects of AKT-targeted therapeutic agent in metastatic triple-negative breast cancer. Dramatic results were observed, with the survival period of the patients under targeted therapy reported to be about twice as long as that of the control group. Diarrhea was the most common adverse effect among the patients treated with the targeted therapeutic agent, while serious adverse effects such as death did not occur at all.

  32. 08.2017 Professor Seo Dae-cheol of Neurological Intervention Clinic attempts new EE method for cerebral aneurysm

    The anterior choroidal artery (AChaA) that separates from the internal carotid artery that supplies blood to the brain is a very important blood vessel, as it affects the motor nerves of our body. AChaA aneurysms have been difficult to treat by endovascular embolization (EE) because the AChaA became easily obstructed by the coil coming out from the cerebral aneurysm after the procedure. Professor Seo Dae-cheol of the Department of Radiology developed a method of bending the microcatheter and inserting in the opposite direction from the AChaA when inserting the coil to treat patients with AChaA aneurysms. It has been announced that the application of this new method resulted in no recurrence or adverse effects.

  33. 08.2017 Brain stereotactic radiosurgery performed on 10,000 patients in 27 years

    The Radiosurgery Center has recently recorded its 10,000th brain stereotactic radiosurgery case. Brain stereotactic radiosurgery is a non-invasive therapeutic procedure in which the lesion in the head is accurately located based on 3D coordinates and high-dose radiation from multiple directions is focused solely on the tumor site, without affecting the surrounding brain tissue. There are fewer than ten hospitals in the world that have had more than 10,000 cases of brain stereotactic radiosurgery procedures and such hospitals are located in the United States, France, Japan, China, etc. At the Radiosurgery Center of Asan Medical Center, 8,936 gamma knife procedures and 1,064 cyber knife procedures have been performed on patients with brain disease, and a success rate of 90% has been achieved for malignant brain tumors and 95% for benign brain tumors.

  34. 08.2017 Development of medical device to prevent anesthesia awareness during surgery

    “Anesthesia awareness” refers to a phenomenon in which the patient receives surgery in a state of incomplete unconsciousness. Such patients may experience symptoms of post-traumatic stress disorder such as anxiety, fear, and aversion against medical professionals, as they vividly recall the surgical procedure. A joint research team led by Professor No Gyu-jeong, associate professors Choi Byeong-mun and Bang Ji-yeon and Assistant Professor Lee Yong-heon of the Department of Anesthesiology and Pain Medicine discovered a way of measuring the depth of consciousness by converting brain wave signals into entropy, which is a measure of disorder in physics. A medical device (PLE monitor) with the application of the algorithm was fabricated for a clinical study, and it was confirmed that it could be used to measure the state of consciousness of the patient during operation. This medical device has recently been approved by the Ministry of Food and Drug Safety for commercialization purposes.

  35. 08.2017 Cardiovascular stenting technique taught to 1,131 doctors in 33 countries through ACT

    The Asan Medical Center Cardiology Training (ACT) Program, co-hosted by the Heart Institute of Asan Medical Center and the Cardiovascular Research Foundation, was carried out for the 100th time. ACT is an intensive specialist training program in which 10~15 participants are taught the latest cardiovascular intervention trends and know-hows over the course of 3 days through live demonstrations and lectures. The number of program participants by country has been 293 from Korea, 206 from China, 186 from India, 159 from Japan, 41 from Malaysia, 33 from Hong Kong, 32 from Thailand, 15 from Singapore and 1 from the United Arab Emirates thus far. The program in which the participants get to engage in a discussion, while watching a live demonstration of world-class heart operation carried out in the atrium inside the angiocardiography room is highly popular. In addition to the regular courses, there are field-specific programs such as chronic obstructive lesion procedure, aortic valve stenting procedure, bio-absorbable stenting procedure, and cardiovascular image analysis, and individually tailored programs for radiologists and nurses.

  36. 07.2017 Introduction of a dedicated specialist system, resulting in high satisfaction among patients and medical staff

    Our hospital is running a dedicated specialist system for inpatients at Ward 85 of the Oncology Department, with the aim of enhancing patient safety and the quality of our medical service. Under this system, the dedicated medical professors assume full responsibility for all types of medical care from patient admission to discharge including consultation, progress monitoring, counseling, simple treatments and procedures, and discharge planning. A satisfaction survey carried out with 42 discharged patients from Ward 85 as well as 46 medical staff members including professors, clinical lecturers and nurses showed that the medical staff and patients alike were greatly satisfied with the dedicated specialist system for inpatients. 

  37. 07.2017 Interdisciplinary team for stroke dramatically shortens treatment time using thrombolytic agent

    Around 80% of strokes, which is the No. 1 cause of death, are ischemic strokes (cerebral infarction) caused by obstructed blood vessels. A team led by Professor Kim Jong-sung and Associate Professor Jeon Sang-beom at Asan Medical Center in Seoul carried out regular education sessions to instruct 119 paramedics to screen for patients suspected of having a stroke and contact a hotline before transporting them to the hospital. They also organized an interdisciplinary team dedicated to stroke treatment, thereby dramatically shortening the time it takes for stroke examination and treatment procedure. Through these efforts, the average time it takes for a stroke patient to receive thrombolytic therapy after arrival at the hospital has reportedly been reduced from 46 minutes to 20.5 minutes. In addition, the percentage of patients receiving thrombolytic therapy increased 1.6-fold from 9.8% to 15.8%, and the incidence of cerebral hemorrhage, a complication of the procedure, decreased from 12.6% to 2.1%.

  38. 07.2017 Asan International Digestive Disease Symposium held with great success

    The 10th Asan International Digestive Disease Symposium was held in the grand auditorium and seminar halls #1 and #2 on the sixth floor of the east Building on July 14 and 15, 2017. In addition to the 9 speakers invited from 7 countries, some 150 medical professionals and administrative staff members in the field of digestive disease medicine attended the event. At the symposium, there were lectures on ▲ the latest therapeutic methods and diagnostic methods for gastroesophageal reflux disease, ▲ the latest advances in obesity treatment, and ▲ the new diagnostic and therapeutic methods for gastrointestinal and pancreatic diseases, in addition to ▲ a hands-on course on echo-endoscopy. Dr. Mark Noah from Howard County General Hospital of the Johns Hopkins Medicine network and Dr. Robert Bailey from the University of Alberta in Canada were invited for an in-depth discussion and debate on the therapeutic methods for gastroesophageal reflux disease and obesity using endoscopy as well as on primary biliary cholangitis. 

  39. 07.2017 Doctor trained at Asan Medical Center successfully performs first heart transplant in Vietnam

    Cho Ray Hospital, the largest national hospital in Vietnam, had the surgical capacity to perform heart transplants, yet lacked the capacity for pre- and post-op care, which is highly important when it comes to the surgery. Dr. Nguyen Tat Dat, specializing in internal medicine, came to our hospital to receive training in pre- and post-op heart transplant care. Near the end of the training, he was contacted by the staff of Cho Ray Hospital, who informed him of an impending heart transplant, and he rushed back home to prepare for the operation. On May 30, the first heart transplant in Vietnam was carried out at Cho Ray Hospital. The result was a success, and thanks to the excellent pre- and post-op care provided, the patient was discharged in good health one month after the operation.

  40. 07.2017 Safe treatment of congenital heart defects using 3D cardiac ultrasound

    A team led by Professor Song Jong-min of the Department of Cardiology announced the findings of their study that using 3D cardiac ultrasound, which enables precise determination of the hole size and shape prior to a percutaneous closure of atrial septal defect (ASD), can enhance the safety and efficiency of the procedure. Professor Song’s team performed the procedure on 195 ASD patients after determining the exact size and shape of the hole in the heart using transesophageal echocardiogram and reported a success rate of 99% and a mortality rate of 0%.

  41. 07.2017 Development of drug delivery technology that enhances anticancer effects

    When it comes to maximizing the effectiveness of anticancer agents, what is important is effectively delivering the drug to the target site, where the tumor is. A team formed by Professor Choi Eun-Kyoung and Associate Professor Song Si-Yeol of the Department of Radiation Oncology and Associate Professor Jeong Seong-Yun discovered a peptide that strongly binds with a cancer marker in the blood and developed a technique to carry the peptide and an anticancer agent on a nanomaterial to be delivered to cancer cells. The results of their study showed that cancer growth was inhibited by up to 96.3% in the intervention group compared to the control group. Also, by identifying the protein counterparts to cancer tissues that strongly binds to the selected peptide, it is expected to help develop the imaging technology for diagnosis, in addition to cancer treatment.

  42. 07.2017 Non-surgical endoscopic removal of cysts with high risk for pancreatic cancer

    Although most cystic tumors (cysts) in the pancreas are benign, they can potentially develop into cancer if left untreated, and thus they are typically removed by surgery in the early stages. A team led by Professor Seo Dong-Wan of the Department of Gastroenterology became the first in Korea to introduce the endoscopic ultrasound (EUS)-guided removal procedure for cystic tumors of the pancreas. Professor Seo’s team made long-term observations, for an average of 6 years, of 158 patients who had received the endoscopic ultrasound (EUS)-guided removal procedure for cystic tumors of the pancreas after July 2005. The results showed a complete tumor removal in 114 patients (72%), while in 27 patients (17.1%), the tumors were sufficiently reduced to a size that required only follow-up observations. As such, the therapeutic effects of the procedure were shown to be excellent in a total of 141 patients (89.1%). Furthermore, complications occurred in only 16 (10.1%) of the 158 patients, indicating a decrease in the risk of complications by one-third compared to the conventional surgical method.

  43. 06.2017 The first successful artificial retina transplant by a team led by Prof. Yoon Young-hee of ophthalmology

    Retinitis pigmentosa (RP) is the most common form of inherited retinal diseases that develops as retinal cells which were normal at birth are functionally disordered over time. A retinal implant has internal units to be implanted in a patient and an external unit to be worn by a patient. A surgery team led by Professor Yoon Young-hee of the department of ophthalmology transplanted an artificial retina into a patient suffering from RP. Visual information is obtained via a camera and processed with a special portable computer to be delivered to the internal unit through an antenna and then signaled to the visual center. The patient could dimly make out strong light two weeks after transplant and read the biggest letters on an eyesight test chart one month after transplant.

  44. 06.2017 A team led by Professor Kim Jae-seung concludes an agreement to export a 10 billion won-worth new technology for diagnosing Parkinson’s disease to Australia

    FP-CIT which is a radiopharmaceutical developed by a research team led by Professor Kim Jae-seung and Associate Professor Oh Seung-jun of the Department of Nuclear Medicine  and Specialist Lee Sang-ju in 2008 and obtained an approval from the Ministry of Food and Drug Safety was first exported.

    The research team has signed a contract of an international exclusive license of the patent with a consortium of DuChemBio Co., Ltd. – Korean distributor and supplier of radiopharmaceuticals – and BGM – German consulting firm – to export FP-CIP in June last year. As a result, a 10 billion won-worth contract for technology export was signed with Australian company CYCLOTECH to sell FP-CIP in Australia and New Zealand.

  45. 06.2017 Shingles patients to have a higher risk of cardio-cerebrovascular diseases

    A joint research team led by Associate Professor Kim Sung-han of the Department of Infectious Diseases, Associate Professor Yoon Sung-cheol of the Department of Medical Statistics, and Professor Kwon Sun-uck of the Department of Neurology has analyzed the study group of 23,233 shingles patients registered in database of the National Health Insurance Corporation and the control group of the same number of patients without shingles between 2003 and 2013. As a result, it was found that shingles patients are more likely to have heart diseases by 1.41 times, a stroke by 1.35 times, and myocardial infraction by 1.59 times. In particular, a risk of having a stroke in shingles patients under the age of 40 is higher than the control group by 3.74 times.

    The correlation between shingles and cardio-cerebrovascular diseases was most noticeable in the first year when shingles develops and gradually decreasing over time. Moreover, shingles were closely related to hypertension, diabetes, dyslipidemia, angina, peripheral vascular diseases, rheumatism, and malign tumors as well as cardio-cerebrovascular diseases.

  46. 06.2017 AMC achieves world-class survival rates of lung transplantation.

    AMC lung transplantation team (Professors Park Seung-il and Kim Dong-kwan and Assistant Professor Cho Se-hoon of the Dept. of Thoracic and Cardiovascular Surgery, Professors Shim Tae-sun and Hong Sang-bum of the Dept. of Pulmonology and Critical Care Medicine, and Professor Lee Sang-oh of the Dept. of Infectious Disease) has analyzed 41 patients who underwent lung transplantation until the end of last year from 2008 and recently announced that five-year survival rates are 65.5%. It represents that the survival rates of lung transplantation in Korea has reached the global level. According to the Korean Network for Organ Sharing (KNOS), one-year, three-year, and five-year survival rates of lung transplantation in Korea are 81.4%, 76.9%, and 65.5%, respectively. Meanwhile, the International Society for Heart and Lung Transplantation (ISHLT) reported that one-year, three-year, and five-year survival rates of lung transplantation in the world are 85%, 67%, and 61%, respectively. AMC achieved an international level of performance.

  47. 05.2017 Hepatitis B requiring many drugs due to resistance is cured with a single drug

    A research team led by Professor Lim Young-suk of the department of internal medicine has recently published the study result that a single drug administration is effective in controlling the activity of the virus.

    The research team followed up 192 patients for 144 weeks (3 years) and compared the treatment effects in chronic hepatitis B with multidrug resistance between a Tenofovir-based single therapy and a Tenoforvia-Entecavir-based combined therapy. There was almost no difference in effects between the two therapies. The Tenofovir-based single therapy was also used in all patient subjects including both groups for 96 weeks, and found the ratio of patients without showing the activity of hepatitis B virus rose to about 74% while no one was resistant to Tenofovir.

  48. 05.2017 Prof. Yook Jeong-hwan of stomach surgery verifies the effectiveness of iron infusion with IV for anemia after stomach cancer surgery.

    Professor Yook Jeong-hwan of the department of stomach surgery published a study result that iron infusion with IV is effective in treatment acute lsovolemic anemia that occurs after stomach cancer surgery. This study was carried out jointly with surgeons who specialized in stomach cancer from seven large hospitals in Korea as well as a research team from the Graduate School of Cancer Science and Policy of the National Cancer Center. It is expected that the practice of improper transfusion will be replaced with iron infusion with IV since this study discovered that simply raising the hemoglobin level can alleviate anemia.”  

  49. 05.2017 A conference to celebrate the opening of the Health Innovation Big Data Center is held.

    A ‘Status and Future Trend of Medical Big Data’-themed conference to celebrate the opening of the Health Innovation Big Data Center was held on June 9 and attended by external lecturers from various organizations such as IBM, Microsoft, LG Electronics, and National Health Insurance Cooperation as well as around 200 medical professionals and researchers to share recent insights on big data. AMC has been committed to building a Korean-type big data analysis platform since September 2014 and opened the Health Innovation Big Data Center this year. Recently a medical big data competition was also held jointly with Microsoft Korea. Now AMC focuses on refining various medical big data such as EMR data and medical images to be utilized in R&D.

  50. 05.2017 AMC signs the MOU with the Korea Brain Research Institute for brain disorder study and brain bank development.

    AMC signed the MOU with the Korea Brain Research Institute (KBRI), a government-funded research institution, on May 17 to cooperate for the study of human brain disorders and develop a brain bank. They will work together to build a Korea brain bank network that collects, stores, and offers normal and diseased human brain tissues, cooperate with brain disease-related technologies, and discover joint research areas. 

  51. 04.2017 A meeting for the use of 3D printing technology in a clinical setting

    A meeting for the use of 3D printing technology in a clinical setting was held on April 11 at the grand auditorium (6F, East Building), attended by government officials including Acting President Hwang Kyo-ahn, Vice Minister of Health and Welfare Bang Moon-kyu, and Minister of Food and Drug Safety Sohn Mun-gi as well as internal and external medical professionals including Director General of Asan Healthcare System Lee Sung-gyu, President of AMC Lee Sang-do, and Chairman of Asan Institute for Life Sciences Kim Chong-jai. Assistant Professor Kim Nam-kug of the department of convergence medicine gave a presentation on “Development, application, and commercialization of medical 3D printing technology: Beyond regulations and obstacles; and discussion on public-private cooperation to promote the use of 3D printing technology was conducted.

  52. 04.2017 AMC have trained 2,283 overseas medical professionals from 82 countries for five years.

    For the last five years from 2012 to 2016, 2,283 overseas medical professionals have come to AMC to learn sophisticated and advanced medical skills. Especially last year, a record number of 617 overseas medical professionals visited AMC for training. In 2016, the department preferred the most by overseas medical professionals was the department of cardiology (111), followed by the department of radiology (104) and the department of liver transplantation and hepatobiliary surgery (94).

    AMC provides overseas medical professionals with information for dormitory and library use through the Asan Medical International (AMI) in order to help them adjust to a strange environment. Recently, an orientation session for overseas medical professionals of diverse nationalities, was created to encourage them interact with one another and promote a network of Asan alumni.

  53. 04.2017 A clinical study of prevention of otitis media recurrence with balloon dilation is conducted.

    A research team led by Professors Song Ho-young of the department of radiology and Park Hong-ju of the department of otorhinolaryngology will conduct a clinical study of balloon dilation for treatment of hearing problems of recurrent otitis media patients. Balloon dilation involves observation of the auditory tube through endoscopy and radioscopy after local anesthesia, insertion of a tube, and inflation of a balloon to widen the narrowed section. As a result, the widened auditory tube allows proper air circulation, making the secretion stagnant inside the ear naturally flow down into the rear of the nose through the auditory tube to be out of the body, which will eventually prevent otitis media.

  54. 04.2017 AMC Cancer Institute started to develop a biomarker to see the effectiveness of preoperative treatment for rectal cancer.

    AMC Cancer Institute has recently launched the development of a biomarker with European researchers, which is designed to inform of the effectiveness of preoperative chemotherapy and radiotherapy in advance in order to provide customized treatment with rectal cancer patients who are eligible for preoperative chemotherapy and radiotherapy. This project began as Prestizia, a French biotechnology and molecular diagnostics company, proposed AMC having a record of more than 2,000 colorectal cancer surgeries performed to cooperate in R&D activities. On April 20, AMC, Prestizia, and CbsBioscience which is a Korean startup entered into a three-party research agreement. In the next three years, ▲ CbsBioscience will develop a biomarker that predicts the effectiveness of chemotherapy and radiotherapy by patient using the tissue of rectal cancer patients; ▲Prestizia will develop a biomarker using the blood of patients; and ▲AMC will review the effectiveness of each biomarker through clinical trials.

  55. 04.2017 CardioVascular Summit-TCTAP 2017 is successfully held.

    The 22th CardioVascular Summit-TCTAP 2017 was held from three days from April 25 to 27 in the Convention Center of COEX. The Summit organized by the CardioVascular Research Foundation (CVRF) and supported by the Heart Institute of Asan Medical Center has been held annually for 22 years. It was the 22nd TCTAP. Since its beginning in 1995, the TCTAP has expanded partnership sessions with prestigious societies and meetings in the cardiology field of the United States, Japan, China, and Europe to become a global forum attended by thousands of cardiologists from 40 countries every year.

  56. 04.2017 Symposium on gait training assistance robot, Morning Week, is held.

    A symposium was held on April 5 to share the current improvements and clinical study results of Morning Week. The study result was announced that Morning Week-assisted rehabilitation was effective in patients with brain injury including stroke.

  57. 03.2017 AMC performs the 1,000th autologous stem cell transplantations.

    A ceremony that celebrates the 25th anniversary of opening the Hematopoietic Stem Cell Collection of the department of oncology and the performance of 1,000 autologous stem cell transplantations was held on March 11. Since the first autologous stem cell transplantation in January 1993, the 1,000th transplantation was successfully performed on a 59-year old woman in February. AMC has also reported to the American Society of Hematology in 2016 89% of 2-year survival rates of autologous stem cell transplantation on patients with central nervous system lymphoma known for having an unfavorable prognosis.

  58. 03.2017 AMC first proves the effect of drug treatment on aortic valve stenosis in the world.

    A research team led by Professor Song Jae-kwan of the department of cardiology, Associate Professors Jang Eun-ju and Choi Bong-geun at the Department of Medical Lifescience, and Assistant Professor Lee Sah-min of the department of cardiology has recently announced that medical care without surgery can deter the aging of the aortic valve. It was also found that the administration of DPP-4 inhibitor which is used to treat diabetes inhibits the occurrence of calcification in the aortic valves. This study result is especially significant in that it was an outcome of translational research carried out by combining clinical study and basic research based on AMC’s sufficient clinical experience.

  59. 03.2017 AMC signs an agreement for joint research of next-generation medical robots and clinical therapies.

    AMC’s Robot Surgery Center signed an agreement with Intuitive Surgical, a global robotic surgical instrument manufacturer, on March 22 for joint research to promote the development of medical robots, robot-assisted clinical treatment, and surgical techniques. They will go into a joint study to develop next-generation medical robots based on their abundant experience in performing robotic surgery and studying medical robots.  

  60. 03.2017 Professors Kim Jin-soo, Han Duck-jong, Choi Jung-kyoon, and Ahn Jung-min win the 10th Asan Award in Medicine

    The awarding ceremony of the 10th ASAN Award in Medicine was held on March 21 at the Grand Hyatt Seoul. Winners are ▲Director of Center for Genome Engineering Kim Jin-soo at the Institute for Basic Science (basic medicine category) ▲ Professor Han Duck-jong of the department of cardiovascular surgery at AMC (clinical medicine category), ▲Professor Choi Jung-kyoon of the department of bio and brain engineering at KAIST, Professor Ahn Jung-min of the department of internal medicine at the University of Ulsan College of Medicine (young investigator category). Winners received a prize of 700 million won including 300 million won for a winner in basic-clinical medicine category while 50 million won for each winner in young investigator category.

  61. 03.2017 Airway Vista 2017 is successfully held.

    The Airway Vista has been held since 2008 to build a researcher network and share insights on COPD and asthma. The 10th Airway Vista held in an auditorium (6F, East Building) for two days between March 25 and 26 reflected upon the last ten years of COPD research and found the future directions for development. At the symposium attended around 20 world-renowned specialists in COPD-related areas and COPD-related genetics including Professor Norbert F.

  62. 03.2017 AMC’s Global Center of Excellence in Clinical Trials announces project results.

    AMC’s Global Center of Excellence in Clinical Trials has completed projects that have been carried out for the last five years with the outcomes of enhancing its competitiveness in clinical trials and establishing global research infrastructure. For five years, AMC has performed 191 phase-1 clinical studies, 284 phase-2 clinical studies, 511 phase-3 clinical studies, and 129 phase-4 clinical studies as well as 223 PoC (Proof of Concept) studies designed to confirm the efficacy of new therapies on patients. 

  63. 02.2017 AMC was selected in KMAC-led survey as the most admired hospital in Korea for the 11th consecutive years.

    AMC ranked the top in the general hospital category of a survey for the most admired businesses in Korea for the 11th consecutive years. ‘The most admired hospital’ award is given to the hospital with the highest scores for excellent clinical performance and social contribution by patients, their families, and medical professionals.

  64. 02.2017 AMC is admitted to a global research network for immune-oncology.

    AMC has been recently admitted to a global research network for immune-oncology, imCORE (immunotherapy Centers of Research Excellence) for its excellence in competence to perform world-class clinical studies. 

  65. 02.2017 A surgery team led by Prof. Kim Ki-hun of liver transplantation and hepato-biliary surgery performs the 50th laparoscopic surgery of liver donator.

    A surgery team led by Professor Kim Ki-hun of the department of liver transplantation and hepato-biliary surgery performed a total of 51 laparoscopic surgeries of liver donators without a single complication. Laparoscopic liver resection is done inside the abdomen, not only minimizing damage to the liver and its surrounding tissues, but also leading to small scar and less pain, which allows patients to walk again as quickly as possible and is preferred by young women donors. 

  66. 02.2017 A research team led by Prof. Jeon Sang-ryong of neurosurgery starts a preclinical study of customized stem cell medicine for chronic spinal cord injury patients

    A research team led by Professor Jeon Sang-ryong of the department of neurosurgery made a start on a preclinical study of customized stem cell medicine for chronic spinal cord injury patients. The preclinical study is aimed to develop ‘smart stem cells’ added with an effect of helping the regeneration of spinal nerve beyond the effect of cell regeneration. 

  67. 02.2017 Robotic surgery is applied in 11 divisions including urology and the number of robotic surgeries performed increases by 24 times in a decade.

    This year marks the tenth year since AMC introduced a robot-assisted surgery system. According to the Robotic Surgery Center, the number of robotic surgeries performed in AMC was 767 in 2012, 926 in 2013, 173 in 2014, 1,373 in 2015, and 1,749 in 2016, which represents a steady increase in recent five years. Comparing between the figure in 2007 (72) when the first robotic surgery was performed and that in 2016, it increased by 24.3 times in ten years.
     

  68. 02.2017 Medical Volunteering at Tanzania, Africa

    AMC’s medical volunteering team visited Tanzania of Africa from February 3 to 12 to prove medical services. The team set up clinic camps in a village church of Isole, the Katong Gulu health center, and the Illamella hospital ship to perform treatment of internal medicine, surgery, obstetrics and gynecology, ophthalmology, and pediatrics, 54 blood tests, 78 urine tests, 59 ultrasound scanning, pain relief procedures, and surgical interventions for burns, wounds, and dressing. The team treated 2,183 residents of poor farming and fishing villages on the shores of Lake Victoria.

  69. 02.2017 AMC performs 963 organ transplantations in 2016.

    According to the Korean Network for Organ Sharing (KONOS)’s statistics, AMC performed 963 transplantations out of a total of 4,602 organ transplantations performed in 2016. Until February 2017 from January 2000 when the KONOS started collecting data (as of February 28), AMC has performed 10,882 organ transplantations, which accounts for 23.7% of overall organ transplantations in Korea and is the largest number of organ transplantations performed. Since 2000, one in four patients received organ transplantation at AMC. 

  70. 02.2017 Successful simultaneous robotic single-site surgery for liver cancer and colorectal cancer

    AMC has recently succeeded in a robotic single-site surgery for liver cancer and colorectal cancer with a 3~4cm hole and a 1.5cm incision through collaboration with the department of hepatobiliary and pancreatic surgery and the department of colon and rectal surgery. It is unusual to complete a surgery for liver cancer and colorectal cancer with only two incisions using robotic single-site technique like this. The patient is recovering without any complications thanks to minimized incision site and shortened operation time, and satisfied with the surgery because almost no scar remains now two months after surgery

  71. 01.2017 A team led by Prof. Kim Young-hee of thoracic and cardiovascular surgery performs the 200th robotic surgery for esophageal cancer.

    Professor Kim Yong-hee of the department of thoracic and cardiovascular surgery performed the 200th robotic surgery for esophageal cancer on January 2.

    Esophageal cancer surgery is regarded as one of the most sophisticated surgeries due to its long operation time of more than six hours and a high risk for developing complications. Robot-assisted surgery for esophageal cancer will ▲enhance surgical precision by offering a magnified view of nerves and paratracheal lymph nodes ▲easing postoperative pain by minimizing an incision, and ▲reducing complications such as pneumonia.

  72. 01.2017 A team led by Prof. Lee Jung-kyo of neurosurgery cures intractable depression with Gamma Knife.

    A woman who has repeatedly suffered from recurrent depression and attempted suicide due to intractable depression for thirty years, went through gamma knife surgery led by an operation team led by Professor Lee Jung-kyo of the department of neurosurgery, and now overcame depression and live a normal life without medication. She received a surgery three years ago that applies gamma radiation into the brain without opening the skull and a scalp. The treatment team monitored her over two and a half years to find her condition continuously improved and no special neurological abnormality, so that published the results in the Journal of European Neurosurgical Society.

  73. 01.2017 Around 3.05 million patients visit AMC in 2016 with an increase of overseas patients.

    A total of 3,054,905 patients visited AMC last year. The number of outpatients and inpatients was 2,915,191 and 139,714, respectively while the number of surgeries performed was 63,118 with around 254 surgeries performed a day on average.

    According to a survey, a growing number of foreign patients from more diverse nationalities are visiting AMC. Patients from 92 countries received treatment in AMC in 2016, compared to 82 countries in 2012 (see Graph 3). Notably, the number of patients from Saudi Arabia with somewhat different cultural and geographical characteristics was 966 in 2016, which is an increase by 68% from 572 in 2015. AMC has coordinators dedicated to some countries including Saudi Arabia who involves interpretation and optimization of treatment schedules for each patient.

  74. 01.2017 AMC launches AI Medical Imaging Center.

    As AMC was selected as a leading research institute for developing AI source technology to support the interpretation of lung, liver, and heart images and commercializing a connection of medical image storage and transmission systems, we launched the AI Medical Imaging Center’ to make full-fledged efforts to develop AI-related technologies. The Center will develop a variety of core technologies including AI technology-based disease-specific medical imaging software, convergence of voice recognition technology, and medical AI engine development.

  75. 01.2017 Prof. Myung Seung-jae of gastroenterology identifies a new pathogenesis of colorectal cancer.

    A research team led by Professor Myung Seung-jae of the department of gastroenterology has first identified that colon polyp and cancer cells are developed if bioactive substance PGE2 and gene YAP1 which are known to regenerate cells in the body are overly manifested through excessive interactions inside the colon.

  76. 01.2017 A surgery team led by Professor Park Seung-jung of cardiology performed the 300th TAVI.

    A surgery team led by Professor Park Seung-jung of the department of cardiology performed the 300th transcatheter aortic valve implantation (TAVI) on January 17, which was an achievement made in seven years since the first success in TAVI using a stent on a severe aortic stenosis patient in March 2010.

    According to the statistics of 300 TAVIs performed in AMC, an average age of patients was 78.4 years old and the success rate was 96.3%. Especially the procedures performed in 2016 boasts 98% of the success rate. The first patient who received TAVI in Korea in 2010 (now 91 years old) is leading a healthy life.